Generate a tailored SOP for Dr. Jan Grimm. Improve your application with a focused, well-structured draft.
Jan Grimm is a radiologist at the Memorial Sloan Kettering Cancer Center, where he leads research within the Molecular Pharmacology Program. His lab develops innovative approaches to cancer diagnostics and therapy, focusing on the underlying biology of cancer using advanced nanotechnology and imaging techniques. Dr. Grimm's research interests include the use of nanoparticles for cancer treatment, novel imaging methodologies such as Cerenkov and optoacoustic imaging, and the study of prostate-specific membrane antigens in the context of prostate cancer neovasculature. He aims to enhance diagnostic tools and ultimately improve patient care in oncology. Dr. Grimm holds an MD from the University of Hamburg and a PhD from the University of Kiel, contributing to the field of nuclear medicine as he advances the use of modern imaging methods in clinical practice.
Memorial Sloan Kettering Cancer Center • New York, NY
Lead research in the Molecular Pharmacology Program focusing on innovative approaches to cancer diagnostics and therapy.
Administered through the Gerstner Sloan Kettering (GSK) Graduate School. The program focus is Cancer Biology and includes faculty from the Department of Molecular Pharmacology.